KRO-13141
(2R)-2-(phenylmethoxycarbonylamino)pent-4-enoic acid; D-Cbz-Allylglycine
127474-54-8
98% min.
scale-up (10-1,000 kg)
C13H15NO4
98% min.
scale-up (10-1,000 kg)
C13H15NO4
KRO-13136
(2S)-2-(phenylmethoxycarbonylamino)pent-4-enoic acid
78553-51-2
98% min.
scale-up (10-1,000 kg)
C13H15NO4
98% min.
scale-up (10-1,000 kg)
C13H15NO4
KRO-15696
2-[(2-methylpropan-2-yl)oxycarbonylamino]pent-4-enoic acid; DL-Boc-Allylglycine
119479-32-2
98% min.
scale-up (10-1,000 kg)
C10H17NO4
98% min.
scale-up (10-1,000 kg)
C10H17NO4
KRO-15496
D-Allylglycine methyl ester hydrochloride; (R)-Methyl 2-aminopent-4-enoate hydrochloride
217440-34-1
98% min.
scale-up (10-1,000 kg)
C6H12ClNO2
98% min.
scale-up (10-1,000 kg)
C6H12ClNO2
KRO-15497
3-VINYL-D-ALANINE; (R)-allylglycine; (R)-2-Allylglycine; D-C-ALLYLGLYCINE; (R)-2-allyl-Gly; H-D-ALGLY-OH; H-D-Gly(Ally)-OH; (2R)-2-amino-4-pentenoic acid; D-Allyiglycine; H-D-GLY(ALLYL)-OH; (R)-2-amino-4-pentenoic acid; (2R)-2-aminopent-4-enoic acid; (R)-2-aminopent-4-enoic acid; (R)-2-Amino-4-pentenoic acid; H-ALLYL-D-GLYCINE; D-a-Allylglycine
54594-06-8
98% min.
scale-up (10-1,000 kg)
C5H9NO2
98% min.
scale-up (10-1,000 kg)
C5H9NO2
KRO-26651
ATS-8; (4R,6R)-6-Cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester; tert-Butyl (4R,6R)-6-CyanoMethyl-2,2-diMethyl-1,3-dioxane-4-acetate; tert-Butyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxolane-4-acetate; (4R-cis)-1,1-Dimethylethyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
125971-94-0
98% min.
scale-up (10-1,000 kg)
C14H23NO4
98% min.
scale-up (10-1,000 kg)
C14H23NO4
KRO-14626
isoquinoline-3-carboxylic acid hydrazide; isochinoline-3-carbohydrazide
1119545-63-9
98% min.
scale-up (10-1,000 kg)
C10H9N3O
98% min.
scale-up (10-1,000 kg)
C10H9N3O
KRO-30204
3-cyano-4-(1-methylethyloxy)benzoic acid; 4-isopropoxy-3-cyanobenzoic acid; 3-Cyano-4-isopropoxy-benzoic acid
258273-31-3
98% min.
scale-up (10-1,000 kg)
C11H11NO3
98% min.
scale-up (10-1,000 kg)
C11H11NO3
KRO-49440
1,2,3,4-tetrahydronaphth-1-ylamine; Aminotetralin [Czech]; EINECS 220-973-7; 1-aminotetralin; 1,2,3,4-Tetrahydro-1-naphthylamine; 1,2,3,4-Tetrahydro-1-naphthylaMine; 1-Amino-1,2,3,4-tetrahydro-naphthalene; 2-Aminotetralin
2217-40-5
98% min.
scale-up (10-1,000 kg)
C10H13N
98% min.
scale-up (10-1,000 kg)
C10H13N
KRO-46777
(-)-(1S,4R)-N-Boc-g-homocycloleu-2-ene; (1S,4R)-4-((tert-Butoxycarbonyl)amino)cyclopent-2-enecarboxylic acid; (-)-(1S,4R)-N-BOC-4-AMINOCYCLOPENT-2-ENE-4-CARBOXYLIC ACID; (1S,4R)-(-)-4-N-BOC-aminocyclopent-2-ene-1-carboxylic acid; (1S-cis)-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-cyclopentene-1-carboxylic acid; (1S,4R)-Boc-4-aminocyclopent-2-ene-carboxylic acid; (1S,4R)-(-)-4-(BOC-AMINO)-2-CYCLOPENTENE-1-CARBOXYLIC ACID; (1S,4R)-4-(tert-butoxycarbonylamino)cyclopent-2-enecarboxylic acid; (1R,4S)-N-Boc-1-Aminocyclopent-2-ene-4-carboxylicacid(e.e.); (1S,4R)-(-)-4-(Boc-amino)-2-cyclopentene-1-carboxylic acid; (1S,4R)-4-[(tert-butyloxycarbonyl)amino]cyclopent-2-enecarboxylic acid; (1S,4R)-4-(tert-butoxycarbonyl)cyclopent-2-enecarboxylic acid; 4S) (4-hydroxymethyl)-cyclopent-2-en1-yl carbamic acid tertbutyl ester; (1S,4R)-N-tert-butoxycarbonyl-4-aminocyclopent-2-ene-1-carboxylic acid; N-BOC-(1S,4R)-(-)-4-AMINOCYCLOPENT-2-ENE-1-CARBOXYLIC ACID
151907-79-8
98% min.
scale-up (10-1,000 kg)
C11H17NO4
98% min.
scale-up (10-1,000 kg)
C11H17NO4
KRO-46892
(6r,7s)-2-boc-2-aza-bicyclo[2.2.1]hept-5-en-3-one
151792-53-9
98% min.
scale-up (10-1,000 kg)
C11H15NO3
98% min.
scale-up (10-1,000 kg)
C11H15NO3
KRO-02488
Winsef; Cefoselis (sulfate); (6R-(6alpha,7beta(Z)))-7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-((2,3-dihydro-2-(2-hydroxyethyl)-3-imino-1H-pyrazol-1-yl)methyl)-8-oxo-5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid sulfate; FK 037
122841-12-7
98% min.
scale-up (10-1,000 kg)
C19H24N8O10S3
98% min.
scale-up (10-1,000 kg)
C19H24N8O10S3
KRO-03371
(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonyl amino)pyrinidine-5-yl]-3,5-dihydrosy-6-heptane acid methyl ester; (+)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl)-(3R,5S,6E)-dihydroxy-hept-6-enoic acid methyl ester; methyl (3R,5S,6E)-7-[4-(4-flurophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidyl]-3,5-dihydroxy-6-heptenoate; (3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)]-2-[methyl(methylsulfonyl)amino-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid methyl ester; methyl (6E)-7-{4-(4-flurophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}(3R,5S)-3,5-dihydroxyhept-6-enoate; X6287; 7-[4-(4-fluorophenyl)-6-isopropyl-2-(methylsulfonyl-methyl-amino)pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid methyl ester; (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid methyl ester; Rosuvastatin methyl ester; AC-3412
147118-40-9
98% min.
scale-up (10-1,000 kg)
C23H30FN3O6S
98% min.
scale-up (10-1,000 kg)
C23H30FN3O6S
KRO-03374
(+)-ethyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxy-6(E)-heptenoate; ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid ethyl ester; ROSUVASTATIN ETHYL ESTER; 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-(N-methyl-N-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid ethyl ester; (3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)]-2-[methyl(methylsulfonyl)amino-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid ethyl ester; (E)-(+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methansulfonyl-methylamino)-pyrimidin-5-yl]-(3R,5S)-dihydroxy-hept-6-enoate ethyl ester; (+)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl)-(3R,5S,6E)-dihydroxy-hept-6-enoic acid ethyl ester
851443-04-4
98% min.
scale-up (10-1,000 kg)
C24H32FN3O6S
98% min.
scale-up (10-1,000 kg)
C24H32FN3O6S
KRO-03372
tert-Butyl rosuvasta; Rosuvastatin intermediate R-3; Rosuvastatin t-Butyl Ester; Rosuvastatin tert-butyl ester; ZD-8; Rosuvastatin calciuM interMediate R-3
355806-00-7
98% min.
scale-up (10-1,000 kg)
C26H36FN3O6S
98% min.
scale-up (10-1,000 kg)
C26H36FN3O6S
KRO-17796
(3R,6E)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-oxo-6-heptenoic acid methyl ester; methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-(E)-6-heptenate; methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-(E)-6-heptenoate; Methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-yl]-(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-(6E)-heptanoate; 6-Heptenoic acid,3-[[(1,1-diMethylethyl)diMethylsilyl] oxy]-7-[4-(4-fluorophenyl)-6-(1-Methylethyl)-2-[Methyl (Methylsulfonyl)aMino]-5-pyriMidinyl]-5-oxo-,Methyl ester,(3R,6E); methyl 7-[4-(4-flourophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-(E)-6-heptenoate; methyl 7-[4-(4-fluorofenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)-pyrimidin-5-yl]-(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-(E)-6-heptenate; methyl (3R,6E)-3-[[(1,1-dimethylethyl)dimethylsilyl]-oxo]-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidyl]-5-oxo-6-heptenoate
147118-38-5
98% min.
scale-up (10-1,000 kg)
C29H42FN3O6SSi
98% min.
scale-up (10-1,000 kg)
C29H42FN3O6SSi
KRO-32312
ZD-6; methyl (3R,6E)-7-[4-(4-flurophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)mino]-5-pyrimidyl]-3-hydroxy-5-oxo-6-heptenoate; Methyl(+)-(3-R)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-(N-Methyl-N-Methanesul fonylaMino) pyriMidin-5-y; Methyl (+)-(3R)-7-[4-(4-fluorophenyl)- 6-isopropyl-2-(N-Methyl-NMethansulphonylaMino) pyriMidin-5-yl]-3-hydroxy-5-oxo- 6(E)-heptenoate; (3R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoic acid methyl ester; (R,E)-Methyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-MethylMethylsulfonaMido)pyriMidin-5-yl)-3-hydroxy-5-oxohept-6-enoate; methyl 7-[4-(4-flourophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)-pyrimidin-5-yl]-(3R)-3-hydroxy-5-oxo-(E)-6-heptenate; 7-[4-(4-fluorophenyl)-6-isopropyl-2-(methylsulfonyl-methyl-amino)pyrimidin-5-yl]-3-hydroxy-5-oxo-hept-6-enoic acid methyl ester; methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)-pyrimidin-5-yl]-(3R)-3-hydroxy-5-oxo-(E)-6-heptanate; 5-Oxorosuvastatin methyl ester; Methyl 7-[4-(4-FLUOROPHENYL)-6-ISO-PROPYL-2-(N-METHYL-N-METHYLSULFONYLAMINO)PYRIMIDIN-5-YL]-(3R,5R)-DIHYDROXY-(E)-6-HEPTENATE; methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R)-3-hydroxy-5-oxo-(E)-6-heptenate; methyl 7-[4-(4-flourophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R)-3-hydroxy-5-oxo-(E)-6-heptenoate; Methyl(+)-(3-R)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methanesul fonylamino) pyrimidin-5-yl]-3-hydroxy-5-oxo-6(E)-heptenoate
147118-39-6
98% min.
scale-up (10-1,000 kg)
C23H28FN3O6S
98% min.
scale-up (10-1,000 kg)
C23H28FN3O6S
KRO-27533
4-(4-fluorophenyl)-6-isopropyl-2-[(methanesulfonyl)methylamino]pyrimidine-5-carboxylic acid ethyl ester
147118-30-7
98% min.
scale-up (10-1,000 kg)
C18H22FN3O4S
98% min.
scale-up (10-1,000 kg)
C18H22FN3O4S
KRO-26643
(4R,6S)-6-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester; tert-Butyl (3R,5S)-6-hydroxy-3,5-O-isopropylidene-3,5-dihydroxyhexanoate; tert-Butyl 2-[(4R,6S)-6-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate; (4R,6S)-6-Hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester; tert-Butyl (4R,6S)-6-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxane-4-acetate; 2-[(4R,6S)-6-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetic Acid tert-Butyl Ester
124655-09-0
98% min.
scale-up (10-1,000 kg)
C13H24O5
98% min.
scale-up (10-1,000 kg)
C13H24O5
KRO-26644
6S)-6-(acetoxyMethyl)-2; 3-dioxan-4-yl)acetate; (4R-CIS)-6-[ (ACETYLOXY)METHYL ]-2,2-DIMETHYL-1; 2-[(4R,6S)-6-(Acetoxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetic acid tert-buthyl ester; (4R-CIS)-6-[(ACETYLOXY)METHYL]-2,2-DIMETHYL-1,3-DIOXANE-4-ACETIC ACID,T-BUTYL ESTER; tert-butyl 2-((4R; tert-butyl 2-[(4R,6S)-6-(acetoxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate; (4R,6S)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid; tert-butyl 2-{(4R,6S)-2,2-dimethyl-6-[(methyl-carbonyloxy)methyl]-1,3-dioxan-4-yl} acetate; tert-Butyl (4R-cis); 1,1-dimethylethylester; (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid,1,1-dimethylethyl ester; rosuvastatin interMediates D-5; tert-Butyl(4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate
154026-95-6
98% min.
scale-up (10-1,000 kg)
C15H26O6
98% min.
scale-up (10-1,000 kg)
C15H26O6